Change Control Best Practices - Avoiding Unintended Consequences of Changes
Website https://www.complianceonline.com/fda-change-control-expectations-best-practices-seminar-training-802 |
Edit Freely
Category
Deadline: July 17, 2020 | Date: July 27, 2020-July 28, 2020
Venue/Country: Virtual Seminar, U.S.A
Updated: 2020-06-24 19:56:50 (GMT+9)
Call For Papers - CFP
One of the top 10 FDA 483 and Warning Letter citations is for inadequate change control. Change control receives detailed scrutiny during FDA inspections, and FDA reviews change control documentation to determine that changes did not adversely impact products, processes, equipment, facilities, etc. A single inadequate change may lead to significant negative events, including release of sub-standard product or product recall. A pattern of inadequate changes may require costly and time-consuming system remediation efforts.Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.